Meissner Will Exhibit at CPHI 24-26, October 2023, in Barcelona

Meissner is excited to announce its participation in the CPHI, Barcelona event. The show will take place 24-26, October 2023, at Fira de Barcelona Gran Via, Spain. Meissner will host visitors in Stand 3D22.

Meissner will be focused on introducing new innovations to help optimize biotech manufacturing operations. This will include Meissner’s new ZebragardTM PVDF membrane barrier filter that was developed to facilitate final fill and finish applications requiring PUPSIT (pre-use post-sterilization integrity testing). It will also include XytoFlexTM biocontainer assemblies, which have been optimized for cell expansion applications on suspension-based cell lines. Other Meissner highlights will include the SepraPor® hollow fiber filters for both microfiltration and ultrafiltration applications, the CryoVault® freeze and thaw platform for critical biopharmaceuticals, UltraSnap® high-capacity filter assemblies that incorporate both pre- and final filtration in one ready-to-use assembly, and the AccuFlux® automated filter integrity tester.

CPHI Worldwide, now CPHI Barcelona, is one of the largest international pharmaceutical events of the year and is committed to delivering a sustainable event that is environmentally and socially responsible. According to their website, “Each year CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences, and online communities to network, identify business opportunities, and expand the global market. Hosting events in Europe, China, Korea, India, Japan, South East Asia and North America, CPHI co-locates with ICSE for contract services, PMEC for machinery, equipment, and technology, InnoPack for pharmaceutical packaging, bioLIVE or BioProduction for biopharma and FDF for every aspect of the finished dosage supply chain.” For more information about CPHI worldwide, visit their website at www.cphi.com.

Meissner manufactures advanced microfiltration products and single-use systems for critical pharmaceutical and biopharmaceutical applications, such as sterilization of injectable drugs, and processing of life-enhancing/life-saving therapies. For more information, call Meissner U.S. Headquarters at +1-805-388-9911, or visit www.meissner.com.

Contact:
Meissner Corporation (USA)
Karisa Koenig
Director of Marketing
karisa.koenig@meissner.com
1001 Flynn Road
Camarillo, CA 93012

Meissner (Ireland)
Castlebar Business & Technology Park
Drumconlan, Castlebar
Co. Mayo F23 P961

Download Spec Sheet

All Topics